Clinical Trial Update: Safety and Tolerability of AZD5148 in Japanese Participants [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of AZD5148 in Japanese participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• AZD5148

Snippet

Sponsor: AstraZeneca | Conditions: Clostridioides Difficile Infection | Phase 1 | Status: COMPLETED